Laboratorios Farmaceuticos ROVI SA
LSE:0ILL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Laboratorios Farmaceuticos ROVI SA
LSE:0ILL
|
ES |
|
Alstom SA
OTC:AOMFF
|
FR |
|
S
|
Sanofi SA
XHAM:SNW
|
FR |
Wall Street
Price Targets
0ILL Price Targets Summary
Laboratorios Farmaceuticos ROVI SA
According to Wall Street analysts, the average 1-year price target for
0ILL
is 84.29 EUR
with a low forecast of 70.2 EUR and a high forecast of 95.92 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is 0ILL's stock price target?
Price Target
84.29
EUR
According to Wall Street analysts, the average 1-year price target for
0ILL
is 84.29 EUR
with a low forecast of 70.2 EUR and a high forecast of 95.92 EUR.
What is Laboratorios Farmaceuticos ROVI SA's Revenue forecast?
Projected CAGR
13%
For the last 14 years the
compound annual growth rate for
Laboratorios Farmaceuticos ROVI SA's revenue is
10%.
The projected
CAGR
for the next 3 years is
13%.
What is Laboratorios Farmaceuticos ROVI SA's Operating Income forecast?
Projected CAGR
21%
For the last 14 years the
compound annual growth rate for
Laboratorios Farmaceuticos ROVI SA's operating income is
18%.
The projected
CAGR
for the next 3 years is
21%.
What is Laboratorios Farmaceuticos ROVI SA's Net Income forecast?
Projected CAGR
22%
For the last 14 years the
compound annual growth rate for
Laboratorios Farmaceuticos ROVI SA's net income is
16%.
The projected
CAGR
for the next 3 years is
22%.
